CBIO
Crescent Biopharma, Inc. Common Stock
CBIO
CBIO
44 hedge funds and large institutions have $31.7M invested in Crescent Biopharma, Inc. Common Stock in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 9 increasing their positions, 19 reducing their positions, and 6 closing their positions.
Holders
44
Holders Change
-3
Holders Change %
-6.38%
% of All Funds
0.7%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
9
Reduced
19
Closed
6
Calls
$132K
Puts
$3K
Net Calls
+$129K
Net Calls Change
+$247K